<DrugInformationSummary id="CDR0000750074"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>This page contains brief information about trametinib
         dimethyl sulfoxide and a collection of links to more information about the use of 
         this drug, research results, and ongoing clinical trials.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/trametinib">Trametinib</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000599034">trametinib dimethyl sulfoxide</TerminologyLink><GlossaryLink ref="CDR0000750072">trametinib dimethyl sulfoxide</GlossaryLink><USBrandNames><USBrandName>Mekinist</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>truh-MEH-tih-nib dy-MEH-thul sul-FOK-side</TermPronunciation><MediaLink ref="CDR0000752689" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000752688" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0002ad27-779d-42ab-83b5-bc65453412a1&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Trametinib Dimethyl Sulfoxide</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0002ad27-779d-42ab-83b5-bc65453412a1&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Trametinib
         dimethyl sulfoxide is approved 
         to be used alone or with <GlossaryTermRef href="CDR0000750069" dictionary="Cancer.gov" audience="Patient">dabrafenib mesylate</GlossaryTermRef> to treat patients whose cancer has a certain <GlossaryTermRef href="CDR0000046063" dictionary="Cancer.gov" audience="Patient">mutation</GlossaryTermRef> in the <GeneName><GlossaryTermRef href="CDR0000561325" dictionary="Cancer.gov" audience="Patient">BRAF</GlossaryTermRef></GeneName> gene, including:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000044541" dictionary="Cancer.gov" audience="Patient">Anaplastic thyroid cancer</GlossaryTermRef></Strong>  that has spread and cannot be treated with <GlossaryTermRef href="CDR0000045755" dictionary="Cancer.gov" audience="Patient">local therapy</GlossaryTermRef>. It is used with dabrafenib mesylate.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000044541" dictionary="Cancer.gov" audience="Patient">Glioma</GlossaryTermRef></Strong>  that is <GlossaryTermRef href="CDR0000386213" dictionary="Cancer.gov" audience="Patient">low grade</GlossaryTermRef> in children aged  1 year and older who require <GlossaryTermRef href="CDR0000045922" dictionary="Cancer.gov" audience="Patient">systemic therapy</GlossaryTermRef>. It is used with dabrafenib mesylate.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045135" dictionary="Cancer.gov" audience="Patient">Melanoma</GlossaryTermRef>.</Strong> It is used:<ItemizedList Style="bullet" id="_6"><ListItem>With dabrafenib mesylate in  patients who have had surgery to remove cancer that has spread to the <GlossaryTermRef href="CDR0000045762" dictionary="Cancer.gov" audience="Patient">lymph nodes</GlossaryTermRef>.</ListItem><ListItem>Alone or with dabrafenib mesylate in patients whose cancer cannot be removed by surgery or has spread to other parts of the body.</ListItem></ItemizedList></ListItem>
   
   <ListItem><Strong><GlossaryTermRef href="CDR0000045323" dictionary="Cancer.gov" audience="Patient">Non-small cell lung cancer</GlossaryTermRef></Strong> that has spread to other parts of the body. It is used with dabrafenib mesylate.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045301" dictionary="Cancer.gov" audience="Patient">Solid tumors</GlossaryTermRef>.</Strong> It is used with dabrafenib mesylate in adults and children aged 6 years and older whose tumors cannot be removed by surgery or have spread to other parts of the body and have gotten worse after other treatment and cannot be treated with other therapies.¹</ListItem></ItemizedList>
  <Para id="_15">¹This use is approved under FDA’s <ExternalRef xref="https://www.fda.gov/ForPatients/Approvals/Fast/ucm405447.htm">Accelerated Approval Program</ExternalRef>. As a condition of approval, a <GlossaryTermRef href="CDR0000799146" dictionary="Cancer.gov" audience="Patient">confirmatory trial(s)</GlossaryTermRef> must show that trametinib dimethyl sulfoxide provides a clinical benefit in these patients.</Para><Para id="_4">Trametinib
         dimethyl sulfoxide is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Trametinib Dimethyl Sulfoxide</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/599034">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.72">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a613040.html">Trametinib Dimethyl Sulfoxide</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.73"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.74">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2022/rhabdomyosarcoma-trametinib-ganitumab-shrinks-tumors">Drug Combination Shows Promise for Rhabdomyosarcoma, but Can It Get to Clinical Trials?</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2022/fda-dabrafenib-trametinib-braf-solid-tumors">Dabrafenib–Trametinib Combination Approved for Solid Tumors with BRAF Mutations</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2022/melanoma-treatment-androgen-receptor">Androgen Receptor May Explain Sex Differences in Melanoma Treatment Response</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2022/glioma-brain-cancer-dabrafenib-trametinib">For Some Kids with Brain Cancer, Targeted Therapy Is Better than Chemo</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy for Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2022/trametinib-low-grade-serous-ovarian-cancer">Trametinib Is a New Treatment Option for Rare Form of Ovarian Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C152711">Find Clinical Trials for Trametinib Dimethyl Sulfoxide</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2013-06-21</DateFirstPublished><DateLastModified>2024-12-05</DateLastModified></DrugInformationSummary>
